David R Strong1, Eric Leas2, Madison Noble2, Martha White2, Kevin C Frissell3, Allison Glasser4, Lauren Katz4, Kristie Taylor3, Wilson M Compton5, Kevin P Conway5, Elizabeth Lambert5, Heather L Kimmel5, Marushka L Silveira6, Victoria Green6, Lynn C Hull7, K Michael Cummings8, Andrew Hyland9, Ray Niaura4. 1. Cancer Prevention & Control Program, Moores Cancer Center University of California, San Diego, United States; Department of Family Medicine and Public Health, University of California, San Diego, United States. Electronic address: dstrong@ucsd.edu. 2. Cancer Prevention & Control Program, Moores Cancer Center University of California, San Diego, United States; Department of Family Medicine and Public Health, University of California, San Diego, United States. 3. Westat, Rockville, MD, United States. 4. College of Global Public Health, New York University, United States. 5. National Institute on Drug Abuse (NIDA/NIH), Bethesda, MD, United States(1). 6. National Institute on Drug Abuse (NIDA/NIH), Bethesda, MD, United States(1); Kelly Government Solutions, Rockville, MD, United States. 7. Center for Tobacco Products, FDA, Silver Spring, MD, United States. 8. Medical University of South Carolina, United States. 9. Roswell Park Cancer Institute, Buffalo, NY, United States.
Abstract
BACKGROUND AND AIMS: Building on published work1 establishing concurrent validity of a self-report tobacco dependence (TD) index among users of different tobacco products in Wave 1 (W1) of the Population Assessment of Tobacco and Health (PATH) Study, the current study examines prospective relationships with tobacco use behaviors to establish predictive validity of the TD index. Hypotheses suggested high levels of W1 TD would be associated with persistent tobacco use at Wave 2 (W2). PARTICIPANTS: A U.S. nationally representative sample of 32,320 adult W1 and W2 interviews focused on 11,615 W1 adults who were current established tobacco users and completed the W2 interview. FINDINGS: Higher TD scores and greater changes in TD scores were associated with greater quantity and frequency of tobacco use at the W2 interview for Cigarette Only (n = 7068), Smokeless (smokeless or snus pouches) Only (n = 772), Cigarette plus E-Cigarette (n = 592), and Multiple Products (n = 1866) users, although not significantly so for E-Cigarette Only (n = 367), Cigar Only (traditional, cigarillo, or filtered) (n = 584), or Hookah Only (n = 366) users. Higher TD was associated with decreased odds of successful quitting for Cigarette and Multiple Product users. Higher TD was associated with increased odds of a quit attempt for those in the Hookah and Multiple Products user groups and was not associated with quit attempts or deceased odds of quit success among exclusive E-Cigarette, Cigar, Smokeless and Cigarette plus E-Cigarette users. CONCLUSION: Support for the predictive validity of the PATH Study measures of adult TD will enable regulatory investigations of TD across several tobacco products.
BACKGROUND AND AIMS: Building on published work1 establishing concurrent validity of a self-report tobacco dependence (TD) index among users of different tobacco products in Wave 1 (W1) of the Population Assessment of Tobacco and Health (PATH) Study, the current study examines prospective relationships with tobacco use behaviors to establish predictive validity of the TD index. Hypotheses suggested high levels of W1 TD would be associated with persistent tobacco use at Wave 2 (W2). PARTICIPANTS: A U.S. nationally representative sample of 32,320 adult W1 and W2 interviews focused on 11,615 W1 adults who were current established tobacco users and completed the W2 interview. FINDINGS: Higher TD scores and greater changes in TD scores were associated with greater quantity and frequency of tobacco use at the W2 interview for Cigarette Only (n = 7068), Smokeless (smokeless or snus pouches) Only (n = 772), Cigarette plus E-Cigarette (n = 592), and Multiple Products (n = 1866) users, although not significantly so for E-Cigarette Only (n = 367), Cigar Only (traditional, cigarillo, or filtered) (n = 584), or Hookah Only (n = 366) users. Higher TD was associated with decreased odds of successful quitting for Cigarette and Multiple Product users. Higher TD was associated with increased odds of a quit attempt for those in the Hookah and Multiple Products user groups and was not associated with quit attempts or deceased odds of quit success among exclusive E-Cigarette, Cigar, Smokeless and Cigarette plus E-Cigarette users. CONCLUSION: Support for the predictive validity of the PATH Study measures of adult TD will enable regulatory investigations of TD across several tobacco products.
Authors: Megan E Piper; Thomas M Piasecki; E Belle Federman; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Timothy B Baker Journal: J Consult Clin Psychol Date: 2004-04
Authors: Stevens S Smith; Megan E Piper; Daniel M Bolt; Michael C Fiore; David W Wetter; Paul M Cinciripini; Timothy B Baker Journal: Nicotine Tob Res Date: 2010-03-15 Impact factor: 4.244
Authors: David R Strong; Karen Messer; Sheri J Hartman; Kevin P Conway; Allison C Hoffman; Nikolas Pharris-Ciurej; Martha White; Victoria R Green; Wilson M Compton; John Pierce Journal: Drug Alcohol Depend Date: 2015-04-27 Impact factor: 4.492
Authors: Andrew Hyland; Bridget K Ambrose; Kevin P Conway; Nicolette Borek; Elizabeth Lambert; Charles Carusi; Kristie Taylor; Scott Crosse; Geoffrey T Fong; K Michael Cummings; David Abrams; John P Pierce; James Sargent; Karen Messer; Maansi Bansal-Travers; Ray Niaura; Donna Vallone; David Hammond; Nahla Hilmi; Jonathan Kwan; Andrea Piesse; Graham Kalton; Sharon Lohr; Nick Pharris-Ciurej; Victoria Castleman; Victoria R Green; Greta Tessman; Annette Kaufman; Charles Lawrence; Dana M van Bemmel; Heather L Kimmel; Ben Blount; Ling Yang; Barbara O'Brien; Cindy Tworek; Derek Alberding; Lynn C Hull; Yu-Ching Cheng; David Maklan; Cathy L Backinger; Wilson M Compton Journal: Tob Control Date: 2016-08-08 Impact factor: 7.552
Authors: Ian M Fearon; Alison C Eldridge; Nathan Gale; Mike McEwan; Mitchell F Stiles; Elaine K Round Journal: Regul Toxicol Pharmacol Date: 2018-09-08 Impact factor: 3.271
Authors: Karin A Kasza; Nicolette Borek; Kevin P Conway; Maciej L Goniewicz; Cassandra A Stanton; Eva Sharma; Geoffrey T Fong; David B Abrams; Blair Coleman; Liane M Schneller; Elizabeth Y Lambert; Jennifer L Pearson; Maansi Bansal-Travers; Iilun Murphy; Yu-Ching Cheng; Elisabeth A Donaldson; Shari P Feirman; Shannon Gravely; Tara Elton-Marshall; Dennis R Trinidad; Daniel A Gundersen; Raymond S Niaura; K Michael Cummings; Wilson M Compton; Andrew J Hyland Journal: Int J Environ Res Public Health Date: 2018-11-09 Impact factor: 3.390
Authors: John P Pierce; Ruifeng Chen; Sheila Kealey; Eric C Leas; Martha M White; Matthew D Stone; Sara B McMenamin; Dennis R Trinidad; David R Strong; Tarik Benmarhnia; Karen Messer Journal: JAMA Netw Open Date: 2021-10-01
Authors: Erin J Miller Lo; William J Young; Ollie Ganz; Eugene M Talbot; Richard J O'Connor; Cristine D Delnevo Journal: Int J Environ Res Public Health Date: 2022-02-17 Impact factor: 4.614